Sector: Pharmaceuticals & Biotechnology - Healthcare
BSE Code: 524604
NSE Symbol: ADLINE
ISIN: INE276T01018
📋 Adline Chem Lab Appoints New Company Secretary & Compliance Officer • Ms. Gokani Gopika Mukesh (ACS - 76662) appointed as Company Secretary and Compliance Officer • Appointment effective from April 2, 2026 • Appointment approved by Board of Directors based on recommendation from Nomination and …
📋 Adline Chem Lab Appoints New Company Secretary & Compliance Officer • Ms. Gokani Gopika Mukesh (ACS No. A76662) appointed as Company Secretary and Compliance Officer. • Appointment effective from April 2, 2026. • Previous Company Secretary, Ms. Akshita Khandelwal (ACS No. 63342), resigned on Au…
📋 Adline Chem Lab Seeks Shareholder Approval for New Chairman & MD • Appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613) as Chairman and Managing Director for a 5-year term starting February 10, 2026 • Proposed remuneration includes a fixed monthly salary of INR 50,000, with potential an…
Adline Chem Lab Proposes New Chairman & MD 👔 • Mr. Vrushank Balkrushna Patel (DIN: 05310613) nominated as Chairman and Managing Director • Proposed term: 5 years, starting February 10, 2026 • Brings over 12 years of experience across real estate, ceramic tiles manufacturing, green energy, and nat…
Adline Chem Lab Announces New Leadership 👔 - Mr. Vrushank Balkrushna Patel appointed as Chairman and Managing Director for five years, effective February 10, 2026 - Appointment subject to shareholder approval at upcoming General Meeting - Replaces Mr. Sarang Pathak, who resigned as Director - Mr.…
Adline Chem Lab Q3 FY2026 Results & Leadership Update 📊👨💼 • Board approved unaudited standalone financial results for Q3 FY2026 (quarter ended December 31, 2025) • Appointed Mr. Vrushank Balkrushna Patel as Chairman & Managing Director for 5 years starting February 10, 2026, subject to shareho…
Adline Chem Lab Q3 Results & Leadership Update 📊 - Unaudited standalone financial results for Q3 (quarter ended December 31, 2025) to be approved - Mr. Vrushank Balkrushna Patel appointed as Chairman & Managing Director, effective February 10, 2026 - His tenure will continue until March 4, 2029 -…
Adline Chem Lab CFO Steps Down 🚪 - Mr. Kuldip Ashokkumar Parekh resigned as CFO of Adline Chem Lab Ltd (formerly Kamron Laboratories Ltd). - Resignation effective June 13, 2025, due to other commitments and career opportunities. - Board accepted the resignation in their meeting on June 13, 2025. …
🔍 Adline Chem Lab Shareholder Reclassification Approved by BSE – Key Changes - BSE approved reclassification of 12 promoter shareholders to public shareholders. - Key shareholders reclassified include Balkrishna B. Patel (53,900 shares, 0.92%), Jagrutiben J. Laskari (53,900 shares, 0.92%), and Ga…
Key Leadership Changes at Adline Chem Lab Ltd 🏢 - Mr. Sarang Bharatbhai Pathak (DIN: 02663344) resigned as Executive Director & Chairperson, effective November 12, 2025, due to personal reasons. - Mr. Hemant Amrish Parikh (DIN: 00027820) resigned as Non-Executive Promoter Director, effective Nove…
Adline Chem Lab Q2 2025 Update: Key Leadership Changes & Financial Snapshot 📊 - Unaudited Standalone Financial Results for Q2 & Half Year ended Sept 30, 2025 approved. - Mr. Sarang Pathak (Exec Director-Chairman) & Mr. Hemant Parikh (Non-Exec Promoter Director) resigned effective Nov 12, 2025. - …
📅 Adline Chem Lab Ltd: Key Board Meeting & Financial Review on Nov 12, 2025 - Board meeting scheduled for November 12, 2025. - Agenda includes approval of Standalone Unaudited Financial Results for Q2 and H1 ending September 30, 2025. - Limited Review Report by Statutory Auditors will be reviewed…
Key Leadership Change at Adline Chem Lab Ltd: Company Secretary Resigns 📅 - Ms. Akshita Khandelwal resigns as Company Secretary & Compliance Officer of Adline Chem Lab Ltd. - Resignation effective from close of business hours on August 14, 2025. - Reason cited: personal and unavoidable circumstan…
📅 Adline Chem Lab Q1 Results: Board Meeting on Aug 12, 2025 - Board meeting scheduled for August 12, 2025 to approve Q1 (June 30, 2025) unaudited financial results - Statutory auditors' limited review report will be considered - Trading window closure in effect from July 1, 2025 until 48 hours af…